Berry Genomics Co.,Ltd (SZSE: 000710)
Health Care · Biotechnology · CN
CN¥10.31
+12.43% today · -37.9% 1Y
Berry Genomics Co.,Ltd (SZSE: 000710) operates in the Biotechnology industry within the Health Care sector. The company is valued at $542.19M and employs 1,331 people.
Over the last twelve months the share price has lost 37.9%, trading between 7.20 and 17.37.
Tweenvest scores Berry Genomics Co.,Ltd across four factors: quality 63/100, value 38/100, growth 0/100. Its strongest factor is quality.
000710 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $542.19M
- Revenue (TTM)
- $133.71M
- P/E
- —
- EPS
- -0.59
- Dividend yield
- —
- Beta (5Y)
- 0.42
- 52-week high
- CN¥17.37
- 52-week low
- CN¥7.20
- Avg volume (3M)
- —
- Shares outstanding
- 353.52M
- Employees
- 1,331
- Next earnings
- —
About Berry Genomics Co.,Ltd
Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor genetic testing, NextSeq CN500 gene sequencer, and laboratory solutions. It also provides technology services, such as human genome sequencing, transcriptional regulation, single cell/spatial sequencing, animal and plant genome resequencing, genome denovo sequencing, and microbial sequencing, as well as big data services. The company serves various organizations and facilities, including hospitals, research institutions, universities, and enterprises throughout Mainland China, Hong Kong, Macao, Taiwan, Southeast Asia, the Middle East, and Australia. The company was founded in 2010 and is headquartered in Beijing, China.
- ISIN
- CNE000000PN7
- Founded
- 1997
- Listed since
- Apr 22, 1997
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $266.14 | +0.45% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $440.50 | +0.27% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.69 | +0.39% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.14 | +0.01% |
| argenx SEENXTBR: ARGX | $65.85B | €882.20 | -2.20% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $143.01 | -1.42% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.